European Journal of Chemistry

Simultaneous spectrophotometric determination of drugs lacking peak maxima in their zero-order profiles by graphical or statistical representation of data


Main Article Content

Ragaa Magdy
Ahmed Hemdan
Nermine Victor Fares
Maha Farouk


Trandolapril has no sharp peak in its zero-order spectrum, therefore it is difficult to be measured by direct spectrophotometry. In this study, direct univariate spectrophotometric methods were developed and validated for determination of Trandolapril and Verapamil combination in pure and tablet dosage forms. The first method for measuring both Trandolapril and Verapamil is Absorbance Subtraction (AS), this method depends on the presence of iso-absorptive point in the zero-order curve at 217 nm. It has the advantage of measuring the concentration of both Trandolapril and Verapamil from unified regression equation at the iso-absorptive point. The second, third and fourth methods were applied on the first order spectra of the studied drugs. Second method is Derivative Subtraction (DS) for Trandolapril and Derivative subtraction followed by spectrum subtraction (DS-SS) for Verapamil. The third and fourth methods are constant value and concentration value methods. In the concentration value method, the concentration of the drugs is determined from the graphical representation without the use of regression equations. All the developed methods were validated as per International Conference on Harmonization guidelines and the results proved that the developed methods are simple, accurate, and selective. Moreover, a statistical comparison between the developed methods and a reference method was done. Also, One-way ANOVA statistical test was done between all the proposed spectrophoto-metric methods and results showed no significant differences.

icon graph This Abstract was viewed 1617 times | icon graph Article PDF downloaded 623 times

How to Cite
Magdy, R.; Hemdan, A.; Fares, N. V.; Farouk, M. Simultaneous Spectrophotometric Determination of Drugs Lacking Peak Maxima in Their Zero-Order Profiles by Graphical or Statistical Representation of Data. Eur. J. Chem. 2018, 9, 194-201.

Article Details

Crossref - Scopus - Google - European PMC

[1]. Guay, D. R. Clin. Ther. 2003, 25, 713-775.

[2]. Wiseman, L. R.; McTavish, D. Drugs 1994, 48, 71-90.

[3]. Zannad, F. Drugs 1993, 46, 172-181.

[4]. Duc, L. N.; Brunner, H. R. Am. J. Cardiol. 1992, 70, 27D-34D.

[5]. Sharma, S. K.; Ruggenenti, P. Remuzzi, G. Vasc. Health Risk Manag. 2007, 3, 453-465.

[6]. Franz, D. N.; Cardiovascular Drugs, in Remington: The Science and Practice of Pharmacy, A. R. Gennaro, Editor, Mack Publishing Company, 1995, Pennsylvania. 951.

[7]. Martindale, W.; Reynolds, J.; Royal Pharmaceutical Society of Great Britain. Council., The extra pharmacopoeia. 31st ed. 1996, London: Royal Pharmaceutical Press. XXI, 2739 pages.

[8]. Karlberg, B. E.; Andrup, M.; Oden, A. Blood Press 2000, 9, 140-145.

[9]. Dogan, M.; Basaranoglu, M.; Peker, E.; Akbayram, S.; Sahin, M.; Uner, A.; Caksen, H. Hum. Exp. Toxicol. 2011, 30, 1392-1398.

[10]. Rahman, N.; Hejaz S. N. Farmaco 2004, 59, 529-536.

[11]. Gumustas, M.; Sanli, S.; Sanli, N.; Ozkan, S. A. J. Food Drug Anal. 2012, 20, 588-596.

[12]. Gumieniczek, A.; Hopkala, H. Liq. Chromatogr. Relat. Technol. 2001, 24, 393-400.

[13]. Bhushan, R.; Gupta, D. Biomed. Chromatogr. 2005, 19, 474-478.

[14]. Kowalczuk, D. J. AOAC Int. 2005, 88, 1525-1529.

[15]. Chytil, L.; Strauch, B.; Cvacka, J.; Maresova, V.; Widimsky Jr, J.; Holaj, R.; Slanar, O. J. Chromatogr. B. 2010, 878, 3167-3173.

[16]. Magdy, R.; El‐Khatib, A.; Hemdan, A.; Abd Elaziz, O.; Farouk, M.; Linscheid. M. Drug Test. Anal. 2018, DOI: 10.1002/dta.2357

[17]. Vijayalakshmi, R.; Sowjanya, D.; Archana, S.; Dhanaraju, M. Asian J. Pharm. Clin. Res. 2014, 7(4), 216-218.

[18]. Sakur, A.; Hanan, F. Int. J. Acad. Sci. Res. 2016, 4, 9-19.

[19]. Lotfy, H.; Yasmin, M.; Shereen, M.; Nesma, M.; Mostafa, S. Anal. Chem. Lett. 2017, 7, 30-42.

[20]. Lotfy, H. M.; Hegazy, M. A.; Rezk, M. R.; Omran, Y. R. Spectrochim. Acta A 2014, 126, 197-207.

[21]. Lotfy, H. M.; Tawakkol, S.; Fayez, M.; Fahmy, N.; Shehata, M. Spectrochim. Acta A 2017, 184, 61-70.

[22]. Lotfy, H. M.; Hegazy, M. A.; Rezk, M. R.; Omran, Y. R. Spectrochim. Acta A 2014, 126, 197-207.

[23]. Lotfy, H. M.; Fayez, Y. M.; Tawakkol, S. M.; Fahmy, N. M.; Shehata, M. Anal. Chem. Lett. 2017, 7, 30-42

[24]. Samir, A.; Lotfy, H. M.; Salem, H.; Abdelkawy, M. Spectrochim. Acta A 2014, 128, 127-136.

[25]. ICH, Validation of analytical procedure: Text and methodology Q2(R1). Intrnational Conference On Harmonization; 2005; Geneva.

Supporting Agencies


Dimensions - Altmetric - scite_ - PlumX

Downloads and views


Download data is not yet available.


Metrics Loading ...
License Terms

License Terms


Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License ( By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License ( are administered by Atlanta Publishing House LLC (European Journal of Chemistry).